Published in Biochem Biophys Res Commun on October 14, 2000
The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J (2005) 2.38
p53 Family and Cellular Stress Responses in Cancer. Front Oncol (2014) 1.33
p73 in Cancer. Genes Cancer (2011) 1.33
The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol (2001) 1.29
p53 Family: Role of Protein Isoforms in Human Cancer. J Nucleic Acids (2011) 1.26
Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med (2004) 1.24
p73 plays a role in erythroid differentiation through GATA1 induction. J Biol Chem (2009) 0.91
Regulation of p73 by Hck through kinase-dependent and independent mechanisms. BMC Mol Biol (2007) 0.89
High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line. BMC Res Notes (2009) 0.84
N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy. Oncogene (2012) 0.83
A new invertebrate member of the p53 gene family is developmentally expressed and responds to polychlorinated biphenyls. Environ Health Perspect (2002) 0.78
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (1999) 5.33
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Patterns of transcription of human cytomegalovirus in permissively infected cells. J Virol (1980) 3.08
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ (2008) 2.86
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol (2006) 2.72
Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ (2009) 2.63
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55
Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ (2001) 2.40
Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med (1998) 2.40
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ (2006) 2.25
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood (1994) 2.24
p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol (2010) 2.16
Gene disruption of tissue transglutaminase. Mol Cell Biol (2001) 2.15
Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem (1996) 2.05
Comparative inactivation of viruses by chlorine. Appl Environ Microbiol (1980) 2.04
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Prognostic factors in metastatic breast cancer. Cancer Clin Trials (1981) 1.96
S-nitrosylation regulates apoptosis. Nature (1997) 1.91
Senescence and aging: the critical roles of p53. Oncogene (2013) 1.90
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem (1999) 1.77
Historical demography of Mullerian mimicry in the neotropical Heliconius butterflies. Proc Natl Acad Sci U S A (2004) 1.65
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
FLASH is required for histone transcription and S-phase progression. Proc Natl Acad Sci U S A (2006) 1.56
The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer (2005) 1.54
The growth of the cell death field: an analysis from the ISI-Science citation index. Cell Death Differ (1997) 1.53
Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol (1994) 1.53
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ (2002) 1.49
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? J Clin Oncol (1999) 1.47
Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem (2000) 1.43
The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene (2001) 1.42
ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ (2010) 1.39
Recent trends of ophthalmic diseases in Italy: are official data reliable? Clin Ter (2002) 1.39
Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry (1988) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood (1992) 1.36
Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem (1999) 1.35
Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem (2000) 1.35
Lipoxygenases and their involvement in programmed cell death. Cell Death Differ (2001) 1.35
p63 in epithelial development. Cell Mol Life Sci (2008) 1.33
Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol (2000) 1.32
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun (2000) 1.28
Analysis of somatic mutations at human minisatellite loci in tumors and cell lines. Genomics (1989) 1.28
DNA methylation silences miR-132 in prostate cancer. Oncogene (2012) 1.27
Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol (1988) 1.27
LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res (1999) 1.27
Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem (1995) 1.26
Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest (1995) 1.25
Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol (2000) 1.24
Impalement injuries to the thorax as a result of motor vehicle accidents. Ann Thorac Surg (1987) 1.24
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene (2011) 1.22
How many ways to die? How many different models of cell death? Cell Death Differ (2005) 1.21
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ (1999) 1.20
Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes (2002) 1.20
miR-143 regulates hexokinase 2 expression in cancer cells. Oncogene (2012) 1.19
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death Differ (2012) 1.17
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ (2005) 1.17
FLASH is an essential component of Cajal bodies. Proc Natl Acad Sci U S A (2006) 1.17
Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett (2007) 1.17
Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ (2007) 1.15
Evolution of functions within the p53/p63/p73 family. Ann N Y Acad Sci (2000) 1.13
Structure, function and regulation of p63 and p73. Cell Death Differ (1999) 1.12
The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene (2009) 1.11
Nitric oxide (NO), a signaling molecule with a killer soul. Cell Death Differ (1999) 1.11
DNA damage induces the rapid and selective degradation of the DeltaNp73 isoform, allowing apoptosis to occur. Cell Death Differ (2004) 1.10
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem (2000) 1.10
Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol (1994) 1.10
Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Am J Clin Pathol (1992) 1.10
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem J (1995) 1.09
Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ (2007) 1.09
The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol (1991) 1.08
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene (2006) 1.08
Assessment of clonality in human tumors: a review. Cancer Res (1990) 1.08
MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene (2012) 1.08
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis (2010) 1.07
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene (2006) 1.06
MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis (2012) 1.05
p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int J Cancer (2000) 1.04